Financials

  • Market Capitalization 3.48 B
  • Employee 145
  • Founded 2015
  • CEO N/A
  • Website www.ideayabio.com
  • Headquarter Delaware, United States
  • FIGI BBG00CTZ4D83
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-27.01
Rapporto prezzo/fatturato
13.99

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1493
TLX
Telix Pharmaceuticals Limited - American Depositary Shares
11.29 USD+0.71%+3.01%-7.69%+78.92%3.82 B USD
1545
VCYT
Veracyte, Inc. - Common Stock
44.02 USD-2.68%-8.27%+7.16%+19.30%3.54 B USD
1561
XENE
Xenon Pharmaceuticals Inc. - Common Shares
35.81 USD-1.73%-5.21%-39.67%-12.21%3.47 B USD
1581
ACAD
ACADIA Pharmaceuticals Inc. - Common Stock
19.41 USD-1.87%-3.72%-30.70%-1.87%3.34 B USD

Notizie